Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

New Technique Can Locate Genes’ On-Off Switches

March 12, 2015 By Stowers Institute for Medical Research

All the cells in an organism carry the same instruction manual, the DNA, but different cells read and express different portions of it in order fulfill specific functions in the body. For example, nerve cells express genes that help them send messages to other nerve cells, whereas immune cells express genes that help them make antibodies.

In large part, this highly regulated process of gene expression is what makes us fully functioning, complex beings, rather than a blob of like-minded cells.

ChIP-nexus enables improved in vivo detection of transcription factors (yellow oval) on DNA, allowing to zoom in on individual binding footprints (data in red and blue). (Credit: Zeitlinger Lab, Stowers Institute for Medical Research)

Despite its importance, researchers still do not completely understand how cells access the appropriate information in the DNA. They know this process is controlled by proteins called transcription factors, which bind to specific sites around a gene and – in the right combination – allow the gene’s sequence to be read.

However, functional transcription factor binding sites in the DNA are notoriously difficult to locate. The large number of transcription factors and cell types allow endless possible combinations, making it incredibly hard to determine where, when and how each binding event occurs. Moreover, results from genome-wide mapping efforts have only added to the confusion by suggesting that transcription factors bind very promiscuously all over the place, even to sites where they do not turn genes on or off.

Now, researchers at the Stowers Institute for Medical Research have developed a high-resolution method that can precisely and reliably map individual transcription factor binding sites in the genome, vastly outperforming standard techniques.

With the new technique, which was published March 9, 2015 in Nature Biotechnology, transcription factor binding sites that are likely functional leave behind clear footprints, indicating that transcription factors consistently land on very specific sequences. In contrast, questionable binding sites that were previously detected as bound showed a more scattered unspecific pattern that was no longer considered bound.

“Now we can see the subtleties, and a level of precision that we hadn’t anticipated,” says Stowers Associate Investigator Julia Zeitlinger, Ph.D., lead author of the study that also included Stowers colleagues Qiye He, Ph.D., and Jeff Johnston. “Not only do we see a distinct sequence motif where the transcription factor binds, but we also see additional sequences that seem to contribute to binding specificity. There is a lot more information that we can now read to understand how these factors act on the genetic code to influence expression.”

Over the last 15 years, a number of techniques have emerged to enable researchers to map where transcription factors bind to the genome. All of these techniques build on a method called chromatin immunoprecipitation or ChIP, which essentially tethers the proteins to their positions on the DNA, chops the DNA into manageable chunks, and then isolates the sections that are bound by the proteins.

Researchers have taken a variety of approaches to determine the sequence contained within these sections. ChIP-chip uses microarrays or gene chip technology to find the general neighborhood where a transcription factor’s footprint has appeared. ChIP-seq improves upon this approach by using the latest sequencing technologies, but still cannot pinpoint the exact address of the footprint.

The breakthrough came with ChIP-exo developed by Frank Pugh, Ph.D. and colleagues at Penn State University, which uses the addition of an enzyme called exonuclease to trim back the DNA fragments to the spot where the transcription factor is bound. Though this latest technique has promised to reveal the exact address of each transcription factor, its practical implementation had fallen short.

After several attempts to get the ChIP-exo technique to work in her laboratory, Zeitlinger decided to develop her own version. Having worked with ChIP-chip or ChIP-seq for over 15 years, Zeitlinger recognized that the much smaller amounts of DNA obtained by ChIP-exo made it very hard to obtain accurate sequence information. While helping a student working on an unrelated RNA technique, she saw a potential solution.

Normally, when researchers prepare a strip of DNA for analysis, they have to add an extra bit of sequence that serves as a kind of start site for the sequencing machinery. Traditionally, this prep involves two inefficient “ligation” steps, adding a bit of sequence first to the front and then to the back of each sample.

Zeitlinger and her colleagues figured out a way to accomplish the same feat in just one ligation step, adding a bit of sequence to the back of the fragment and then letting the strand form a circle. In addition, the researchers included a random bar code in the bit of DNA they used for ligation, which enabled them to catch any errors or artifacts that might arise in the sequencing procedure.

They called the new method “ChIP experiments with nucleotide resolution through exonuclease, unique barcode and single ligation” or ChIP-nexus. When they used ChIP-nexus to map the footprints of four well-known proteins – namely, human TBP and Drosophila NF-kappaB, Twist and Max– they found that it consistently outperformed existing ChIP-seq protocols in resolution and specificity.

The new tool could distinguish real footprints, those generated by a transcription factor sitting tightly on a particular sequence for a long time, from background noise, that may have arisen from a protein pausing on a sequence in its search for the right landing spot. Having a better collection of real footprints in turn provides much more detailed sequence information on the binding preferences of transcription factors.

Zeitlinger thinks the technique represents an important step forward for the field and will ultimately supplant ChIP-seq for the study of gene regulation.

“We still have a very simplistic idea of how transcription factors come in, open up the DNA, and turn on genes,” says Zeitlinger. “If we do this kind of analysis for lots of transcription factors, we will gather information needed to better understand gene expression.”

In particular, she would like to see the technique used to ask how small changes in DNA — the kind that exist naturally in the human population — affect transcription factor binding and therefore differences in gene expression from one individual to the next.

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech